Growth inhibition by fusidic acid in cervical, thyroid, and breast carcinoma cell linesopen access
- Authors
- Kim, Jin Young; Jega, Bo Seul; Koh, A. Ra; Park, Kyoung Sik; Kim, Jong Bin; Bae, Jaeman
- Issue Date
- Mar-2023
- Publisher
- Korean Soc Obstetrics and Gynecology (KSOG)
- Keywords
- Fusidic acid; Cervical cancer; Thyroid cancer; Breast cancer
- Citation
- OBSTETRICS&GYNECOLOGY SCIENCE, v.66, no.2, pp.100 - 106
- Indexed
- SCOPUS
KCI
- Journal Title
- OBSTETRICS&GYNECOLOGY SCIENCE
- Volume
- 66
- Number
- 2
- Start Page
- 100
- End Page
- 106
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/188766
- DOI
- 10.5468/ogs.22267
- ISSN
- 2287-8572
- Abstract
- Objective
We investigated the effects of fusidic acid (FA) on human cervical, thyroid, and breast carcinoma cell lines to determine the potential usefulness of FA in cancer treatment.
Methods
Six cancer cell lines (cervical cancer: Caski, HeLa; thyroid cancer: 8505C, TPC1; and breast cancer: MCF-7, MDA-MB-231) were treated with FA. Furthermore the changes in cell growth, cell cycle duration, and extent of apoptosis were analyzed.
Results
After FA treatment, the cancer cells showed a decrease in growth rate. In the cell death assay, the cell populations were similar in each cell type after treatment with FA, indicating that growth inhibition by FA was not related to the induction of apoptosis. FA induced cell cycle arrest at a dose that inhibited growth rate, which varied in different cell types. G0/G1 phase arrest occurs in breast cancer, S phase arrest in 8505C thyroid cancer, and G2/M phase arrest in cervical cancer. These results indicate that FA reduces growth rates by inducing cell cycle arrest.
Conclusion
FA treatment can interfere with cell proliferation by inducing cell cycle arrest in human cervical, thyroid, and breast carcinoma cell lines. Thus, FA can be useful in treating human cervical, thyroid, and breast carcinomas.
- Files in This Item
-
- Appears in
Collections - 서울 의과대학 > 서울 산부인과학교실 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.